270 related articles for article (PubMed ID: 34556063)
1. eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting.
Datzmann T; Kisel W; Kramer J; Dreimann M; Müller-Broich JD; Netzer C; Schaser KD; Schmitt J; Disch AC;
BMC Cancer; 2021 Sep; 21(1):1044. PubMed ID: 34556063
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural adaptation, reliability, and validity of the Russian version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0).
Zaborovskii N; Denisov A; Shapton J; Schlauch A; Ptashnikov D; Masevnin S; Smekalenkov O; Murakhovsky V; Mytyga P; Kondrashov D
J Neurosurg Spine; 2023 Oct; 39(4):568-575. PubMed ID: 37439460
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Thai version of the Spine Oncology Study Group Outcomes Questionnaire version 2.0 to assess Quality of Life in Patients with Spinal Metastasis.
Luksanapruksa P; Phikunsri P; Trathitephun W; Santipas B; Suvithayasiri S; Wattanapaiboon K; Wilartratsami S
Spine J; 2021 Nov; 21(11):1920-1924. PubMed ID: 34010685
[TBL] [Abstract][Full Text] [Related]
4. Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health-related quality of life in patients with spinal metastases.
Versteeg AL; Sahgal A; Rhines LD; Sciubba DM; Schuster JM; Weber MH; Varga PP; Boriani S; Bettegowda C; Fehlings MG; Clarke MJ; Arnold PM; Gokaslan ZL; Fisher CG;
Cancer; 2018 Apr; 124(8):1828-1838. PubMed ID: 29409108
[TBL] [Abstract][Full Text] [Related]
5. Translation and validation of the Dutch Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) to evaluate health-related quality of life in patients with symptomatic spinal metastases.
Gal R; van der Velden JM; Bach DC; Verlaan JJ; Geuze RE; Rutges JP; Verkooijen HM; Versteeg AL
BMC Musculoskelet Disord; 2022 Nov; 23(1):1009. PubMed ID: 36424582
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
7. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
8. Cross-cultural adaptation and validation of the Arabic version of McGill quality of life: revised questionnaire in the patients with cancer.
Omar MT; Al-Malki MH; Bindawas SM; Alnahdi AH; Aljehan GH; M Al-Omari BN; Alhammad SA
Disabil Rehabil; 2024 May; 46(9):1878-1887. PubMed ID: 37144328
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
10. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
11. Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ) 2.0 with its assessment in clinical setting.
Yin M; Sun Z; Ding X; Wang T; Sun Y; Li L; Gao X; Ma J; Huang Q; Xiao J; Mo W
Spine J; 2022 Dec; 22(12):2024-2032. PubMed ID: 36031097
[TBL] [Abstract][Full Text] [Related]
12. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
13. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
Gadisa DA; Gebremariam ET; Ali GY
Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
[TBL] [Abstract][Full Text] [Related]
15. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
[TBL] [Abstract][Full Text] [Related]
16. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
[TBL] [Abstract][Full Text] [Related]
17. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
18. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
[TBL] [Abstract][Full Text] [Related]
19. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.
Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K
J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101
[TBL] [Abstract][Full Text] [Related]
20. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
